Pfizer to seek approval in fall for COVID-19 vaccine use in children aged 2 to 11
New antibody rationally designed for better tumor inhibition
7 May 2021EU sceptical of US push to lift COVID vaccine patents
7 May 2021Pfizer to seek approval in fall for COVID-19 vaccine use in children aged 2 to 11
Emergency use authorization for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. Food and Drug Administration by September, the company said Tuesday.
